Tagamet and Omnicef drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tagamet (cimetidine) and Omnicef (cefdinir). Common drug interactions include amenorrhoea among females and chest pain among males.
The phase IV clinical study analyzes what interactions people have when they take Tagamet and Omnicef. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Tagamet?
Tagamet has active ingredients of cimetidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 9,011 Tagamet users. Check the latest studies of Tagamet.
What is Omnicef?
Omnicef has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 2,774 Omnicef users. Check the latest studies of Omnicef.
15 people who take Tagamet and Omnicef together, and have interactions are studied.

What are the common drug interactions of Tagamet and Omnicef, by gender? *:
female:
- Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Anaemia (lack of blood)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Breast tenderness
- Cellulitis (infection under the skin)
- Cervical dysplasia (abnormal changes in the cells on the surface of the cervix)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Crying
- Cyst (a closed sac)
male:
- Chest pain
- Decreased appetite
- Arthralgia (joint pain)
- Asthma
- Atrioventricular block first degree (heart block first degree)
- Back pain
- Balance disorder
- Benign bone neoplasm (benign (non-cancerous) tumours of the bone)
- Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
- Cardiac failure congestive
What are the common drug interactions of Tagamet and Omnicef, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Decreased appetite
- Pyrexia (fever)
- Febrile neutropenia (fever with reduced white blood cells)
- Aphthous stomatitis (mouth ulcer)
- Difficulty in walking
- Dysstasia (difficulty in standing)
- Pain in extremity
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
10-19:
n/a
20-29:
n/a
30-39:
- Cellulitis (infection under the skin)
- Cervical dysplasia (abnormal changes in the cells on the surface of the cervix)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Cough
- Crying
- Cyst (a closed sac)
- Dehydration (dryness resulting from the removal of water)
- Drug abuse
- Drug abuser
- Drug screen positive
40-49:
- Anxiety
- Chronic kidney disease
- Depression
- Renal failure (kidney dysfunction)
- Suicidal ideation
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal injury (kidney injury)
- Suicide attempt
50-59:
- Acute respiratory failure
- Anaemia (lack of blood)
- Anaemia of chronic disease
- Asthma
- Atrioventricular block first degree (heart block first degree)
- Benign bone neoplasm (benign (non-cancerous) tumours of the bone)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
- Cardiac failure congestive
- Cellulitis (infection under the skin)
60+:
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Chest pain
- Death
- Diarrhoea
- Dyspnoea (difficult or laboured respiration)
- Epistaxis (bleed from the nose)
- Hypersomnia (excessive daytime sleepiness (eds))
- Hypoaesthesia (reduced sense of touch or sensation)
- Nausea (feeling of having an urge to vomit)
What are the existing conditions these people have? *
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 33.33%
- Neuralgia (pain in one or more nerves): 5 people, 33.33%
- Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 26.67%
- Wheezing (a high-pitched whistling sound made while you breath): 4 people, 26.67%
- Dizziness: 3 people, 20.00%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 20.00%
- Infection: 3 people, 20.00%
- Pain: 3 people, 20.00%
- Neck Pain: 3 people, 20.00%
- High Blood Cholesterol: 3 people, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Tagamet and Omnicef?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Tagamet and Omnicef:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tagamet:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Omnicef:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tagamet and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Omnicef and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cimetidine and cefdinir (the active ingredients of Tagamet and Omnicef, respectively), and Tagamet and Omnicef (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Sumatriptan and Pataday - 8 seconds ago
- Drug interactions of Zydone and Oxycontin - 11 seconds ago
- Could Concerta cause Colitis? - 12 seconds ago
- Drug interactions of Montelukast Sodium and Aubagio - 14 seconds ago
- Rowasa vs. Uceris, side effect and effectiveness comparison - 16 seconds ago
- Methylprednisolone and Ondansetron drug interactions for men aged 60+ - 22 seconds ago
- Drug interactions of Calcium and Zinacef - 26 seconds ago
- Pantoprazole Sodium and Weight Gain - Unintentional for Men aged 40-49 - 27 seconds ago
- Pantoprazole Sodium and Weight Gain for Men aged 40-49 - 27 seconds ago
- Pantoprazole Sodium and Weight Increased for Men aged 40-49 - 27 seconds ago